8-K/A
filed December 29, 2022, 6:59 PM ET
ticker BMRA
CIK 0000073290
other material
confidence high
sentiment negative
materiality 0.15
Biomerica corrects 8-K: 2022 Stock Incentive Plan not approved at annual meeting
BIOMERICA INC
- Proposal 5 (2022 Stock Incentive Plan) failed under correct majority-of-outstanding-shares standard; 2,395,243 for, 2,227,813 against, 2,475,235 broker non-votes.
- Original 8-K incorrectly used majority-of-votes-cast standard; amended to reflect correct bylaw requirement.
- All five director nominees elected; advisory say-on-pay and frequency (1 year) approved; Haskell & White LLP ratified as auditor.
- 7,126,662 shares present out of 13,474,338 outstanding; plan needed >3,563,331 affirmative votes based on shares entitled to vote.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOMERICA INC shareholders approved Ratification of advisory vote on named executive officers' compensation at the 2022-12-07 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Proposal No. 2 : The Company’s stockholders ratified the advisory vote on the named executive officers’ compensation. Votes For Votes Against Votes Abstaining Broker Non-Votes 4,570,514 44,365 36,548 2,475,235
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOMERICA INC shareholders approved Ratification of appointment of Haskell & White LLP as independent public accounting firm at the 2022-12-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Proposal No. 4 : The Company’s stockholders ratified the appointment of Haskell & White LLP as the Company’s independent public accounting firm for the fiscal year ending May 31, 2023. Votes For Votes Against Votes Abstaining Broker Non-Votes 7,047,314 70,909 8,439 --
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOMERICA INC shareholders approved Election of Directors at the 2022-12-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Proposal No. 1 : The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors until t he next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or her earlier resignation, death or removal. Nominee Votes For Votes Withheld Broker Non-votes Zackary Irani 4,584,648 66,779 2,475,235 Allen Barbieri 4,571,211 80,216 2,475,235 Catherine Coste 3,977,463 673,964 2,475,235 Jane Emerson, M.D., Ph.D. 3,041,002 1,610,425 2,475,235 David Moatazedi 4,620,764 30,663 2,475,235
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOMERICA INC shareholders rejected Ratification and approval of the Company's 2022 Stock Incentive Plan at the 2022-12-07 meeting.
- Proposal
- equity plan
- Outcome
- failed
- Meeting
- 2022-12-07
Exact text from the filing
Proposal No. 5 : The Company’s stockholders did not ratify and approve the Company’s 2022 Stock Incentive Plan. Votes For Votes Against Votes Abstaining Broker Non-Votes 2,395,243 2,227,813 28,371 2,475,235
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BIOMERICA INC shareholders approved Frequency of future advisory votes on executive compensation at the 2022-12-07 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2022-12-07
Exact text from the filing
Proposal No. 3 : A majority of the Company’s stockholders voted on the option of every one year as the frequency of future advisory votes on executive compensation. Every one year Every two years Every three years Abstain Broker Non-Votes 3,466,478 1,079,888 10,821 94,240 2,623,322
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.